TRIM47 and familial pancreatic carcinoma: As informed in earlier studies, TRIM47 upregulation was related to worse prognosis and promoted malignancy in several tumors including gastric cancer (Xia et al. 2021), pancreatic cancer (Li et al. 2021), breast cancer (Azuma K et al., 2021), and many other carcinomas (Azuma K 2022; Mohammadi et al. 2022).